Formoterol

U-LABA/ICS Effects on Exercise Performance, Formoterol

A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD

Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers

Beta2-adrenergic System and Training

Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)

A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal Block

Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination Treatment

Beta2-adrenergic Agonism and Muscle Remodelling

Methacholine, Long-acting M-cholinolytic and beta2-agonist on the Activity of Beta-receptors in Healthy Volunteers

Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma

Effects of Particle Size in Small Airways Dysfunction

COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers

A Study to Show That Flutiform is Well Tolerated and Effective in the Treatment of COPD

Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)

Efficiency of Twice Daily Formoterol Versus Once Daily Tiotropium in Patients With GOLD A/B COPD

The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations

Efficacy of Indacaterol 150 µg Versus Formoterol

Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer)

Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)